Welcome to Capital Essence

Sign up for a FREE MEMBERSHIP to read tons of free content. Take a 30-DAY Trial Offer to access premium research and trading strategy. Check out our Investment Blog for the latest trading/investment ideas. If you want to go beyond the latest numbers, our Market Outlook will tell you why the market does what it does and what it means for the next day’s trading.

 
One of the more noteworthy developments in recent days has been the move in biotech.  After an impressive run in 2017 the group tumbled out of gate.  The SPDR S&P Biotech ETF (XBI) fell 2 percent this week, underperformed the S&P by a wide margin.  Now the question is whether recent weakness is a pause that refreshes or it’s a beginning of something worse?  Below is an update look at a trade in XBI.

The graphic below is from our “U.S. Market Trading Map”, show the near-term technical bias and trading ranges.  As shown, the underlying is in a short-term bullish trend when the price bars are painted in green.  The underlying is in a short-term bearish trend when the price bars are painted in red. 

Chart 1.1 – SPDR S&P Biotech ETF (weekly)

Our “U.S. Market Trading Map” painted XBI bar in green (buy) – see area ‘A’ in the chart.  XBI rolled over after the late 2017 rally ran out of steam near the prior high set up early October 2017.  This week selloff pushed…Click here to read more.

You see, our trend-following system is very unique as it attempts to pick turns before others see them. Timing is everything and if you’ve applied our system correctly, you should have made a killing in any markets.

 

This is just an example of many successful trades that our member had enjoyed recently. After all, aren’t you glad you subscribed?

Subscribe to CEM News to receive more in-depth research from Capital Essence.

P.S. Take advantage of the 30 days special trial [new member only]. Join a small group of elite traders and receiving these daily trading ideas by click here to subscribe.

Archives

Translate this Page